Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?

Gary R. Cutter, Olaf Stüve

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?'. Together they form a unique fingerprint.

Medicine & Life Sciences